Clinical Trial Update: Safety and Pharmacokinetics of Terbinafine Hydrogen Chloride (HCl) Nail Lacquer in Patients With Onychomycosis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the safety and pharmacokinetics of terbinafine hydrochloride nail lacquer in patients with onychomycosis (and related fungal i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Onychomycosis
• Tinea Pedis

Drugs mentioned

• Terbinafine HCl Nail Lacquer (terbinafine hydrochloride)

Snippet

Sponsor: NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.) | Conditions: Onychomycosis/Onycholysis and Tinea Pedis | Phase 1 | Status: COMPLETED